Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nonvisceral YAP1::TFE3- Rearranged Inflammatory Spindle Cell PEComa in Somatic Soft Tissue : Clinicopathologic and Molecular Analysis of 3 Cases. | Am J Surg Pathol | 2026 | 41521327 | PubTator, text mining | PubMed |
| Plasma membrane-to-lysosome FGR signaling regulates endocytosis-associated lysosome homeostasis. | J Cell Biol | 2026 | 41493272 | PubTator, text mining | PubMed |
| Proteotoxic stress triggers TFEB- and TFE3-mediated autophagy and lysosomal biogenesis via non-canonical MTORC1 inactivation. | Autophagy | 2026 | 41450115 | PubTator, text mining | PubMed |
| Activated T cells degrade extracellular proteins to enhance effector functions. | Cell Rep | 2026 | 41447534 | PubTator, text mining | PubMed |
| STING-driven activation of TFEB/TFE3 establishes a negative feedback loop to control immune homeostasis. | Cell Signal | 2026 | 41391678 | PubTator, text mining | PubMed |
| MiT family translocation carcinomas of the kidney and related entities. | Histopathology | 2026 | 41384707 | PubTator, text mining | PubMed |
| Molecularly defined renal cell carcinomas: practical approaches for surgical pathologists. | Histopathology | 2026 | 41384685 | PubTator, text mining | PubMed |
| Malignant Craniofacial Perivascular Epithelioid Cell Tumor: A Review of Literature With a Rare Presentation. | Head Neck | 2026 | 41367329 | PubTator, text mining | PubMed |
| Differential contribution of TFE3 isoforms to cell motility and invasion. | EMBO Rep | 2026 | 41361692 | PubTator, text mining | PubMed |
| [The WHO Classification of Renal Cell Tumours: Implications for Personalised Treatment Decisions and Accurate Detection of Hereditary Renal Cell Carcinomas]. | Aktuelle Urol | 2026 | 41344358 | PubTator, text mining | PubMed |
| Double trouble: A novel case report of synchronous bilateral renal cell carcinoma of differing histology. | Urol Case Rep | 2026 | 41333113 | PubTator, text mining | PubMed |
| MTOR-mutated eosinophilic renal cell carcinomas with loss of chromosome 1 and high metastatic potential: further expanding the spectrum of TSC/mTOR pathway mutated renal tumors. | Virchows Arch | 2026 | 41299159 | PubTator, text mining | PubMed |
| Conventional FLCN-mutated tumor: a retrospective study of 5 cases with emphasis on diagnostic challenges. | Hum Pathol | 2026 | 41276022 | PubTator, text mining | PubMed |
| NRF2 activation by CDDO-Im regulates inflammatory and autophagy pathways in human microglial cells. | Free Radic Biol Med | 2026 | 41274321 | PubTator, text mining | PubMed |
| Translating molecular mechanisms of epithelioid hemangioendothelioma to improve patient outcome. | Crit Rev Oncol Hematol | 2026 | 41241042 | PubTator, text mining | PubMed |
| Hepatic perivascular epithelioid cell tumor: A rare mesenchymal tumor with epithelioid features: A case report. | Exp Ther Med | 2026 | 41220904 | PubTator, text mining | PubMed |
| Tuberous sclerosis complex-associated renal cell carcinoma, an underappreciated form of familial renal cancer, is characterized by activation of the TFEB/TFE3 pathway. | Hum Mol Genet | 2026 | 41217309 | PubTator, text mining | PubMed |
| SV2B Promotes the Progression of TFE3-Rearranged Renal Cell Carcinoma by Interacting with HERC2 to Impede the Degradation of NF-κB Subunits. | Adv Sci (Weinh) | 2026 | 41199339 | PubTator, text mining | PubMed |
| PEComas of the colon and rectum: a case report of a 15-year-old girl and a review of the pertinent literature. | Clin J Gastroenterol | 2026 | 41182504 | PubTator, text mining | PubMed |
| mTOR-mediated upregulation of B7-H3 in MiT/TFE translocation renal cell carcinoma. | J Pathol | 2026 | 41178060 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=7